The Company was established in 2001.
The Company was initially registered on June 14, 2012 as a limited liability company (OOO Ozon Pharmaceuticals), then as a result of reorganization in the form of transformation into a joint stock company on May 2, 2024.
Ozon Pharmaceuticals is a Russian manufacturer that is represented in all pharmaceutical niches: traditional low-molecular pharmaceuticals, production of highly toxic anti-cancer drugs and complex science-intensive drugs in the field of biotechnology.
The Company s legal address is at TOLYATTI, FRUNZE ST., BLDG. 8, OFFICE 304.
Since October 17, 2024 the Company s shares have been listed on Moscow Exchange under ticket OZPH.
History overview:
2001: established,
5-2024: changed name into Joint Stock Company,
9-2024: changed name into Public Joint Stock Company,
10-2024: listed on MOEX.
Headquarters
Frunze St., Bldg. 8, Office 304
Tolyatti;
Postal Code: 445351
Contact Details: Purchase the Ozon Pharmatsevtika PAO (Озон Фармацевтика ПАО) report to view the information.
Website: http://ozonpharm.ru
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service